Shanghai Golden Leaf Medtec Co. Ltd
Clinical trials sponsored by Shanghai Golden Leaf Medtec Co. Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device zaps kidney nerves to tame stubborn high blood pressure Results expected Dec 2026 (estimated)
- New hope for tough-to-treat high blood pressure? device zaps kidney nerves in trial Results expected Dec 2026 (estimated)
- New device zaps nerves to tame high blood pressure Results expected Mar 2027 (estimated)
- Could zapping kidney nerves ease heart failure? Results expected Apr 2027 (estimated)
-
Could zapping kidney nerves ease heart failure?
Disease control Not yet recruitingThis study tests a procedure called renal denervation (RDN) in 20 people with heart failure. Doctors use a thin tube to deliver radiofrequency energy to nerves around the kidney arteries, aiming to reduce stress on the heart. Participants continue their usual heart failure medica…
Sponsor: Shanghai Golden Leaf MedTec Co. Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New device zaps nerves to tame high blood pressure
Disease control Not yet recruitingThis pilot study tests a device called the Netrod renal denervation system in 20 adults with uncontrolled high blood pressure who are not taking blood pressure pills. The device uses radiofrequency energy to calm overactive kidney nerves, which may help lower blood pressure. Rese…
Sponsor: Shanghai Golden Leaf MedTec Co. Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC